Daily Newsletter

06 September 2023

Daily Newsletter

06 September 2023

Nutex Health hires ex-Bravera Health chief as its COO

With more than two decades of experience in the industry, DeTillio will take on the new responsibility on 2 October 2023.

September 06 2023

US-based healthcare management and operations company Nutex Health has named Joshua DeTillio as its chief operating officer (COO).

DeTillio will take on the new responsibility on 2 October 2023. Prior to joining Nutex Health, he was the CEO of Bravera Health.

His more than two-decade-long career in the industry also includes time at Palms West Hospital, Gulf Coast Medical Center, St Mary’s Medical Center, Cedars Medical Center, North Shore Medical Center, and Aventura Hospital and Medical Center.

In total, he worked for 12 years as a CEO in investor-owned, publicly traded firms, and earlier served as a field artillery officer in the US Army.

DeTillio has degrees from Vanderbilt University, Harvard University, and the US Military Academy at West Point.

Nutex Health president Warren Hosseinion said: “Josh is an exceptional business leader and has demonstrated the ability to grow and manage hospital systems, develop talented leaders, and help hospitals transform, all while delivering strong financial results.

“We look forward to working with him on driving efficient and profitable growth for many years to come.”

Nutex Health’s hospital division operates micro-hospitals, speciality hospitals, and hospital outpatient departments (HOPDs) while its population health management division is responsible for the ownership and operation of provider networks, including independent physician associations (IPAs).

Based in Houston, Texas, the company operates 22 micro-hospitals in eight US states. It uses a cloud-based proprietary technology platform to collect clinical and claims data from diverse sources, enabling a comprehensive view of patients and providers.

Medical robotics set to witness robust growth in the next decade

GlobalData expects every segment of the medical robotics market to grow over the next decade, driven by the demands of high-volume procedures. Per GlobalData forecasts, the surgical robotics market is expected to grow at a CAGR of 8% by 2030. Surgical robots improve patient outcomes, reduce human error, and decrease the length of hospital stays. New surgical robot models will offer new surgical possibilities, such as micro-robots to address difficult-to-treat diseases.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close